Regencell Bioscience Financial Statements
NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD
7.35-0.28 (-3.67%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Regencell Bioscience revenue and earnings
Regencell Bioscience reported a net loss of $11.7 million, compared with a loss of $3.6 million a year earlier. Diluted earnings per share came in at -$2.37.
Summary generated from market data by MetaCap's automated system. Methodology
Regencell Bioscience income statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 11.72M | 3.77M | 4.74M | 6.27M | 7.62M | 1.38M | 812.37K | 390.99K |
| Research & Development | 1.30M | 948.29K | 1.07M | 1.58M | 2.51M | 438.32K | 386.23K | 228.22K |
| Selling, General & Admin | 10.42M | 2.82M | 3.67M | 4.69M | 5.11M | 943.04K | 426.14K | 162.77K |
| Operating Income | -11.72M | -3.77M | -4.74M | -6.27M | -7.62M | -1.38M | -812.37K | -390.99K |
| Other Income (Expense) | 22.52K | 185.77K | 373.50K | 211.34K | — | — | — | — |
| Pretax Income | -11.70M | -3.58M | -4.36M | -6.06M | -7.59M | -1.35M | -812.37K | -390.99K |
| Net Income | -11.70M | -3.58M | -4.30M | -5.87M | -7.45M | -1.35M | -812.37K | -390.99K |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| EPS (Basic) | -2.37 | -0.72 | -0.87 | -1.19 | -0.58 | 0.13 | 0.08 | — |
| EPS (Diluted) | -2.37 | -0.72 | -0.87 | -1.19 | -0.58 | -0.13 | -0.08 | — |
| Shares Outstanding (Basic) | 494.60M | 494.49M | 494.49M | 494.49M | 12.81M | 10.00M | 10.00M | 0.04 |
| Shares Outstanding (Diluted) | 494.60M | 494.49M | 494.49M | 494.49M | 12.81M | 10.00M | 10.00M | 10.00M |
| EBITDA | -11.64M | -3.69M | -4.43M | -5.98M | -7.47M | -1.35M | -802.86K | — |
This table shows 8 annual periods of Regencell Bioscience's income statement, from FY 2026 back to FY 2019, across 12 line items including operating expenses, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow RGC's reporting calendar. What is a income statement?